Orchid Pharma Q2 EBIDTA rises 104%, revenue up 36% on increasing sales
NEW DELHI: Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser sharp focus on costs,...
EBIDTA rises
NEW DELHI: Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser sharp focus on costs,...
